Lind Global Fund II LP - 31 Dec 2025 SCHEDULE 13G/A Report for TENAX THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TENX)

Filing Manager: Lind Global Fund II LP
Reporting Manager: Lind Global Fund II LP
Security: TENAX THERAPEUTICS, INC. Common Stock, par value $0.0001 per share
Symbol: TENX
Shares outstanding: 6,683,988 shares
Disclosed Ownership: 442,480 shares
Ownership: 6.6%
Form type: SCHEDULE 13G/A
Filing time: 17 Feb 2026, 16:08:22 UTC
Date of event: 31 Dec 2025
Previous filing: 14 Nov 2025
SEC: View on sec.gov

Reporting Managers (3)

Name	Ownership	Shares Owned	sole voting power	Signature	Title
Lind Global Fund II LP	6.6%	442,480	442,480	By: Lind Global Partners II LLC, its General Partner, By: /s/ Jeff Easton	Jeff Easton, Managing Member
Lind Global Partners II LLC	6.6%	442,480	442,480	/s/ Jeff Easton	Jeff Easton, Managing Member
EASTON JEFF	6.6%	442,480	442,480	/s/ Jeff Easton	Jeff Easton